Core Viewpoint - The announcement from Health Road (02587) marks a significant transition from a strategic investment phase to a value harvesting phase, with projected revenue of at least RMB 1.5 billion for the fiscal year 2025, representing over 25% year-on-year growth, and a net profit of at least RMB 50 million, indicating a historic turnaround [1] Group 1: Revenue and Profit Growth - The company expects its information technology services revenue to rise from RMB 296 million in 2024 to at least RMB 350 million in 2025, driven by the launch of big data technology services and AI products [1] - Health Road's AI software products are projected to contribute approximately RMB 30 million in scaled revenue by 2025, marking the transition of its AI strategy from concept validation to commercialization [1] Group 2: AI and Operational Efficiency - Health Road has developed a "digital employee" model that effectively addresses efficiency pain points in the healthcare industry, allowing for significant operational cost reductions [2] - The AI assistant for doctors reduces administrative burdens, while the AI health manager provides low-cost chronic disease management and reminders for patients, enhancing operational efficiency [2] Group 3: Market Opportunities - The shift of pharmaceutical companies' marketing budgets towards digital channels opens up a market potential estimated between RMB 800 billion to 1 trillion, as traditional marketing models face systemic upgrades [2] - Health Road's extensive network, connecting over 12,000 hospitals and more than 900,000 registered doctors, positions it as a natural platform for capturing this budget transition [3] Group 4: Content Services and Growth Drivers - The company's content services revenue is expected to surge from RMB 577 million in 2024 to at least RMB 800 million in 2025, becoming a core driver of sustained revenue and profit growth [3] - The implementation of tiered diagnosis and treatment policies and the push for digital health services in county-level medical institutions create a solid foundation for long-term growth [3] Group 5: Strategic Positioning and Future Outlook - Health Road is positioned as a foundational infrastructure in the digital healthcare sector, with a unique dual-end model that enhances its market valuation potential [4] - The anticipated profit turnaround in 2025 is seen as the beginning of value release, with AI technology expected to penetrate more specialized disease management areas and county-level scenarios [4]

此外，和铂医药还将获得最高11亿美元的里程碑付款，以及分级销售分成。公开资料显示，Solstice Oncology为一家多个头部风险投资机构联合创立的临床阶段生物技术公司，此次合作为NewCo模式。 和铂医药-B(02142)早盘涨超8%，截至发稿，涨7.92%，报13.21港元，成交额2179.47万港元。 消息面上，2月23日，和铂医药宣布将新一代CTLA-4抗体HBM4003大中华区外全球权益授权Solstice Oncology，后者支付逾1.05亿美元前期对价，包括5000万美元首付款，500万美元近期付款以及价值逾 5000万美元的公司股权。 ...

公告称，摄像头模组产品销售数量同比增长，主要是由于海外客户需求增加及供应份额持续上升。同 时，其他领域摄像头模组产品的销售情况继续向好，集团应用于物联网(IoT)及智能汽车领域的摄像头 模组销售数量均同比大幅增长。 指纹识别模组产品销售数量同比及环比增长，主要是由于超声波指纹识别模组的行业渗透率持续提升及 客户项目周期影响。 丘钛科技(01478)涨超5%，截至发稿，涨5.68%，报9.11港元，成交额767.33万港元。 消息面上，近日，丘钛科技发布公告，于2026年1月，手机摄像头模组销量为4148.2万件，环比减少 3.7%，同比增加19.5%。摄像头模组销售数量合计4407.1万件，环比减少4.1%，同比增加22.8%。指纹 识别模组销售数量合计1974.1万件，环比增加10%，同比增加18.4%。 ...

消息面上，小摩此前发布研报指出，基于先进逻辑封装领域强劲的资本支出趋势，以及主流外包半导体 封装测试(OSAT)市场出现初步改善迹象，该行将ASMPT列入正面催化剂观察名单。同时，该行将公司 2026及27财年每股盈利预测分别上调7%及15%。 小摩预计，ASMPT将上调其热压焊接(TCB)设备的长期总潜在市场规模预期，并对于在该市场获得更多 市场份额展现信心。同时，公司将提供更多在高频宽记忆体(HBM)热压焊接市场的进展，并指出中国市 场及主流外包半导体封装测试厂商的资本开支环境正变得更加有利。 ASMPT(00522)涨超5%，截至发稿，涨5.53%，报110.7港元，成交额8948.97万港元。 ...

Group 1 - The optical communication concept stocks have shown significant gains, with Changfei Optical Fiber rising by 18.19% to HKD 131.9, Huiju Technology increasing by 8.94% to HKD 17.54, Cambridge Technology up by 5.7% to HKD 67.75, and Hong Teng Precision gaining 3.4% to HKD 5.78 [1] - During the Spring Festival, Huagong Technology's optical module business reported full operation at its production bases in Wuhan and Thailand, ensuring mass production and delivery of high-speed optical modules like 1.6T and 800G [1] - The order backlog for Huagong Technology's connection business extends to Q4 2026, with AI high-speed optical module production lines operating at full capacity 24 hours a day [1] Group 2 - According to a report by Industrial Securities, the combined capital expenditure guidance for Amazon, Google, Meta, and Microsoft is approximately USD 598.7 billion for 2026, reflecting a year-on-year growth of 67% [2] - The demand for AI computing power remains strong, driven by a global arms race, leading to a scaling expansion of data centers and accelerating the commercialization of 1.6T and 3.2T high-speed optical modules [2] - The need for massive computing power is creating a supply-demand gap in critical infrastructure such as optical fibers and liquid cooling, indicating a high level of prosperity across multiple segments of the industry chain [2]

德视佳(01846)发布公告，该公司股份(证券代号：01846)将于2026年2月23日上午九时正起短暂停止买 卖。 ...

长飞光纤光缆公告，公司股票于2026年2月6日至2026 年2月10日连续三个交易日收盘价格涨幅偏离值累 计超过20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形；经公司自 查，并向公司第一大股东中国华信邮电科技有限公司发函询证，截至本公告披露日，不存在应披露而未 披露的重大信息。 智通财经APP获悉，香港联交所最新资料显示，2月23日，长飞光纤光缆(06869)股东将股票由花旗银行 转入摩根士丹利香港证券，转仓市值9.5亿港元，占比2.02%。 ...

周一，拼多多(PDD.US)盘前涨近3%，截至发稿，报108美元。消息面上，2025年第四季度，高瓴、景 林、高毅、东方港湾及喜马拉雅资本等五家头部中资机构的美股持仓动态显示，中概电商龙头拼多多获 集体加仓，成为跨机构的最大共识。据悉，高瓴旗下专注二级市场的HHLR Advisors第一大重仓股拼多 多获大幅增持，持仓市值12.16亿美元，占比从28%升至39%；第二大重仓股阿里巴巴持仓市值7.96亿美 元，占比从14.4%大幅提升至26%。 ...

除Anthropic消息外，软件和科技板块当天早盘已显疲态。三大指数周一收跌，科技板块普遍走低。分 析人士指出，随着AI工具不断向企业级核心系统渗透，市场正在重新评估传统软件和IT服务公司的长期 护城河。IBM股价的急跌，或只是这轮AI驱动的软件板块调整中的又一个缩影。 美股频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 Anthropic在博客中强调，COBOL在现实世界中"无处不在"，美国约95%的ATM交易依赖该语言运行， 数以千亿行的COBOL代码每天在生产环境中支撑着金融、航空和政府等核心系统。但与此同时，真正 理解并能够维护这类代码的人才正逐年减少。 公司表示，Claude的新工具能够自动识别潜在风险，"这些问题如果依靠人工分析，往往需要数月才能 发现"。在Anthropic看来，AI可以让企业以远低于以往的成本完成COBOL系统的分析与优化，从而大幅 压缩对传统IT服务和咨询的依赖。 市场担忧在于，这类AI应用可能直接冲击IBM等公司长期依赖的遗留系统维护、数据服务和咨询业务。 Anthropic在博客中直言，过去多年，遗留代码现代化进展缓慢，原因在于"理解旧代码的成本往往高于 直接重 ...

智通财经获悉，据知情人士透露，在股价暴跌导致市值蒸发近一半后，数字支付先驱PayPal(PYPL.US) 正吸引潜在买家的收购兴趣。受此消息提振，该股周一收涨5.76%，盘中一度上涨9.7%。而其他支付公 司的股价周一普遍因Cattrina Research发布的一份关于人工智能(AI)可能对全球经济各领域构成风险的报 告而下跌。 前首席执行官亚历克斯·克里斯(Alex Chriss)在本月因其转型计划未能达到预期而被免职。该公司2025年 第四季度利润和营收均未达到分析师预期，且支付交易量持续放缓。 不过，瑞穗证券分析师表示，鉴于PayPal是"全球四大知名支付网络之一"，该公司目前"被严重低估";该 公司年交易额接近2万亿美元，并拥有"美国最具影响力的P2P网络"Venmo。KBW分析师也在给客户的 报告中表示，PayPal的网络资产稀缺且具有战略价值，特别对于那些"试图在代理型商务领域发挥更大 作用"的公司而言可能尤为重要。 美股频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 知情人士称，这家总部位于加利福尼亚州圣何塞的公司在收到意向方主动接触后已与多家银行会面。其 中至少有一家大型竞争对手正 ...